Ronawk using stem cell tech developed at Olathe lab to advance liver cancer research in Turkey

October 5, 2021  |  Startland News Staff

Professor Ranan Aktas, Maltepe University

A Kansas City-based biomanufacturing startup announced its first international customer Tuesday: a university team in Istanbul that was among the first to beta test Ronawk’s lauded T-Blocks.

The maker of 3D cell culture products said the collaboration with Professor Ranan Aktas and the Cancer and Stem Cell Research Center at Maltepe University in Turkey will help researchers to better understand cancer development across different environmental conditions using T-Blocks.

“We love working with Professor Aktas’ group and their thoughtful feedback,” said Heather Decker, CTO and co-founder of Ronawk. “We cannot wait to see how the T-Blocks will continue to help and accelerate their research for cancer patients.”

Click here to learn why Ronawk was named one of Startland News’ 2021 Kansas City Startups to Watch.

Ronawk spun out of the University of Kansas’ Department of Plastic Surgery (KUMC) and the Bioengineering Graduate Program in 2019, gained its own manufacturing facility in 2020, and now is making an impact with researchers in 2021, emphasized A.J. Mellott, CEO and co-founder of the startup. Operating from a lab in Olathe, Ronawk was selected this summer for MassChallenge’s 50th accelerator program. 

The T-Blocks product has been recognized as one of the “Coolest Things Made in Kansas” for the past two years by the Kansas Manufacturing Council, an affiliate program of the Kansas Chamber.

Aktas’ group was among 30 pilot studies across the globe that sought to use Ronawk’s bioprinting technologies to develop products that simplify and modernize cell culture practices to accelerate research across virtually all disease specialties. The follow-up purchase of T-Blocks for current and future studies by Maltepe University is a major milestone for Ronawk, Mellott added.

T-Blocks in 6-well plate; image courtesy of Ronawk

T-Blocks in 6-well plate; image courtesy of Ronawk

T-Blocks (Tissue-Blocks) enable researchers to rapidly expand growth of cells — up to one trillion at a time.

“T-blocks have provided an excellent opportunity to investigate the effects of the change in the stiffness of the microenvironment on liver cancer cells and cancer stemness,” said Aktas, describing her team’s interest in the technology. “We will present our first data during the Liver Meeting in Boston and continue creating different micro-environments using T-blocks with various stiffness. We already learned a lot from T- blocks and would love to gather more information using those well-designed 3D scaffolds.”

Click here to read more about the Olathe startup and it’s plan to launch a STEM training facility and create 150 jobs over next seven years.

This story is possible thanks to support from the Ewing Marion Kauffman Foundation, a private, nonpartisan foundation that works together with communities in education and entrepreneurship to create uncommon solutions and empower people to shape their futures and be successful.

For more information, visit www.kauffman.org and connect at www.twitter.com/kauffmanfdn and www.facebook.com/kauffmanfdn

startland-tip-jar

TIP JAR

Did you enjoy this post? Show your support by becoming a member or buying us a coffee.

Tagged , ,
Featured Business
    Featured Founder

      2021 Startups to Watch

        stats here

        Related Posts on Startland News

        How an animal health leader’s $130M investment in KC will boost its fight against canine parovirus

        By Tommy Felts | August 21, 2024

        ELWOOD, Kansas — A $130 million investment from global animal health leader Elanco is a testament to Kansas’ pro-business economy, said Laura Kelly, lauding this week’s expansion announcement and its plans to bring 70 new jobs to the region’s animal health corridor over the next two years. “Elanco’s expansion not only is creating new job…

        Staying transaction-ready in uncertain market conditions

        By Tommy Felts | August 20, 2024

        Editor’s note: The perspectives expressed in this commentary are the author’s alone. The following is a paid thought leadership piece from The Ferguson Smith Cohen Group at Morgan Stanley. In the face of market uncertainty, one thing private companies can control is their “transaction-readiness” for an IPO or secondary offering. Discover three things a company…

        Zee underscores artists’ need for positive venues; creative powerhouse opens pocket of support

        By Tommy Felts | August 20, 2024

        Zahra Briggs developed her creative voice in Kansas City; now she’s setting the stage for fellow independent artists who struggle to find venues that match their vibe — and often have to pay to perform. She’s even creating a version of herself in the metaverse to open access further. A singer and songwriter herself, Briggs — who…

        MyAnIML earns NSF funding, patent; now facing new phase of growth with industry validation

        By Tommy Felts | August 20, 2024

        Thanks to a recent federal grant — along with a newly secured patent on its first-of-its-kind, proprietary facial recognition tech for cows — MyAnIML is proving its place as a leader within a herd of ag innovation, Shekhar Gupta said. The Overland Park startup received a 250,000 Phase I grant from the National Science Foundation…